208 related articles for article (PubMed ID: 36916520)
1. Molecular genetic characteristics of thymic epithelial tumors with distinct histological subtypes.
Yang J; Zhang B; Guan W; Fan Z; Pu X; Zhao L; Jiang W; Cai W; Quan X; Miao S; Nie L; He L
Cancer Med; 2023 May; 12(9):10575-10586. PubMed ID: 36916520
[TBL] [Abstract][Full Text] [Related]
2. Molecular Profiling of Thymoma and Thymic Carcinoma: Genetic Differences and Potential Novel Therapeutic Targets.
Enkner F; Pichlhöfer B; Zaharie AT; Krunic M; Holper TM; Janik S; Moser B; Schlangen K; Neudert B; Walter K; Migschitz B; Müllauer L
Pathol Oncol Res; 2017 Jul; 23(3):551-564. PubMed ID: 27844328
[TBL] [Abstract][Full Text] [Related]
3. The Molecular Landscape of Thymic Epithelial Tumors: A Comprehensive Review.
Elm L; Levidou G
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338833
[TBL] [Abstract][Full Text] [Related]
4. Molecular landscape of thymic epithelial tumors.
Prays J; Ortiz-Villalón C
Semin Diagn Pathol; 2022 Mar; 39(2):131-136. PubMed ID: 34272124
[TBL] [Abstract][Full Text] [Related]
5. Transcriptomic and Mutational Analysis Discovering Distinct Molecular Characteristics Among Chinese Thymic Epithelial Tumor Patients.
Liang N; Liu L; Huang C; Liu H; Guo C; Li J; Wang W; Li N; Lin R; Wang T; Ding L; Mao L; Li S
Front Oncol; 2021; 11():647512. PubMed ID: 34568003
[TBL] [Abstract][Full Text] [Related]
6. Genomic characterization of thymic epithelial tumors reveals critical genes underlying tumorigenesis and poor prognosis.
Tan S; Chen J; Wang Z; Zhao X; Sun Y; Zhu Y; Gong Z; Zhang D
Clin Genet; 2023 May; 103(5):529-539. PubMed ID: 36541162
[TBL] [Abstract][Full Text] [Related]
7. Computed tomography radiomic feature analysis of thymic epithelial tumors: Differentiation of thymic epithelial tumors from thymic cysts and prediction of histological subtypes.
Zhao W; Ozawa Y; Hara M; Okuda K; Hiwatashi A
Jpn J Radiol; 2024 Apr; 42(4):367-373. PubMed ID: 38010596
[TBL] [Abstract][Full Text] [Related]
8. Genomic characterization of thymic epithelial tumors in a real-world dataset.
Kurokawa K; Shukuya T; Greenstein RA; Kaplan BG; Wakelee H; Ross JS; Miura K; Furuta K; Kato S; Suh J; Sivakumar S; Sokol ES; Carbone DP; Takahashi K
ESMO Open; 2023 Oct; 8(5):101627. PubMed ID: 37703595
[TBL] [Abstract][Full Text] [Related]
9. Glut-1 intensity and pattern of expression in thymic epithelial tumors are predictive of WHO subtypes.
Thomas de Montpréville V; Quilhot P; Chalabreysse L; De Muret A; Hofman V; Lantuéjoul S; Parrens M; Payan MJ; Rouquette I; Secq V; Girard N; Besse B; Marx A; Molina TJ
Pathol Res Pract; 2015 Dec; 211(12):996-1002. PubMed ID: 26534878
[TBL] [Abstract][Full Text] [Related]
10. Is (18)F-FDG PET useful in predicting the WHO grade of malignancy in thymic epithelial tumors? A meta-analysis.
Treglia G; Sadeghi R; Giovanella L; Cafarotti S; Filosso P; Lococo F
Lung Cancer; 2014 Oct; 86(1):5-13. PubMed ID: 25175317
[TBL] [Abstract][Full Text] [Related]
11. Mutations of epigenetic regulatory genes are common in thymic carcinomas.
Wang Y; Thomas A; Lau C; Rajan A; Zhu Y; Killian JK; Petrini I; Pham T; Morrow B; Zhong X; Meltzer PS; Giaccone G
Sci Rep; 2014 Dec; 4():7336. PubMed ID: 25482724
[TBL] [Abstract][Full Text] [Related]
12. Frequent Genetic Alterations and Their Clinical Significance in Patients With Thymic Epithelial Tumors.
Xu S; Li X; Zhang H; Zu L; Yang L; Shi T; Zhu S; Lei X; Song Z; Chen J
Front Oncol; 2021; 11():667148. PubMed ID: 34307137
[TBL] [Abstract][Full Text] [Related]
13. Histogenetic and disease-relevant phenotypes in thymic epithelial tumors (TETs): The potential significance for future TET classification.
Yamada Y
Pathol Int; 2023 Jul; 73(7):265-280. PubMed ID: 37278579
[TBL] [Abstract][Full Text] [Related]
14. Vascular architecture as a diagnostic marker for differentiation of World Health Organization thymoma subtypes and thymic carcinoma.
Pfister F; Hussain H; Belharazem D; Busch S; Simon-Keller K; Becker D; Pfister E; Rieker R; Ströbel P; Marx A
Histopathology; 2017 Apr; 70(5):693-703. PubMed ID: 27791295
[TBL] [Abstract][Full Text] [Related]
15. Recurrent genetic aberrations in thymoma and thymic carcinoma.
Zettl A; Ströbel P; Wagner K; Katzenberger T; Ott G; Rosenwald A; Peters K; Krein A; Semik M; Müller-Hermelink HK; Marx A
Am J Pathol; 2000 Jul; 157(1):257-66. PubMed ID: 10880395
[TBL] [Abstract][Full Text] [Related]
16. Expression of c-Jun, p73, Casp9, and N-ras in thymic epithelial tumors: relationship with the current WHO classification systems.
Ma Y; Li Q; Cui W; Miao N; Liu X; Zhang W; Zhang C; Wang J
Diagn Pathol; 2012 Sep; 7():120. PubMed ID: 22974165
[TBL] [Abstract][Full Text] [Related]
17. Clinicogenomic Landscape of Metastatic Thymic Epithelial Tumors.
Ardeshir-Larijani F; Schneider BP; Althouse SK; Radovich M; Masood A; Perna F; Salman H; Loehrer PJ
JCO Precis Oncol; 2023 Feb; 7():e2200465. PubMed ID: 36787505
[TBL] [Abstract][Full Text] [Related]
18. Activation of the mTOR/ Akt pathway in thymic epithelial cells derived from thymomas.
Maury JM; Merveilleux du Vignaux C; Drevet G; Zarza V; Chalabreysse L; Maisse C; Gineys B; Dolmazon C; Tronc F; Girard N; Leroux C
PLoS One; 2019; 14(3):e0197655. PubMed ID: 30897085
[TBL] [Abstract][Full Text] [Related]
19. Thymic Epithelial Tumors phenotype relies on miR-145-5p epigenetic regulation.
Bellissimo T; Ganci F; Gallo E; Sacconi A; Tito C; De Angelis L; Pulito C; Masciarelli S; Diso D; Anile M; Petrozza V; Giangaspero F; Pescarmona E; Facciolo F; Venuta F; Marino M; Blandino G; Fazi F
Mol Cancer; 2017 May; 16(1):88. PubMed ID: 28486946
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics, prognostic factors, and long-term outcomes associated with epithelial malignancies of the thymus: A 20-year single-institution experience.
Altshuler E; Mathavan A; Mathavan A; Krekora U; Mathavan M; Hones K; Daily K
Cancer Rep (Hoboken); 2023 Mar; 6(3):e1750. PubMed ID: 36369906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]